Tuesday, July 9, 2024

The No. 1 Insider Stock for 2024?

Shield

AN OXFORD CLUB PUBLICATION

Liberty Through Wealth

View in browser

SPONSORED

Investing Wizard Who Turned
$37K Into $2.7M in Just 4 Years
Makes His Next Big Move

Nate Beat - Play button
 

He started from nothing and became a multimillionaire...

He's now one of the most sought-after trading experts...

Yet he operates 858 miles from Wall Street.

And now, he's revealing his No. 1 favorite strategy that targets MASSIVE weekly profits with just one stock ticker.

SEE THE PROOF HERE

EDITOR'S NOTE

In 2018, a small group of insiders loaded up on nearly $4 million worth of stock in a little-known company called Tandem Diabetes Care (Nasdaq: TNDM).

Those who followed their lead saw the chance to turn $10,000 into $189,000 in just one year.

That's a staggering 1,795% gain!

Alexander Green has been tracking insider moves like this for decades, and he's ready to share his next big insider opportunity with you.

Click here to see details on Alex's top insider stock pick right now... completely free of charge.

- Nicole Labra, Senior Managing Editor

THE SHORTEST WAY TO A RICH LIFE

Could This Be the Best Insider Stock for 2024?

Alexander Green, Chief Investment Strategist, The Oxford Club

Alexander Green

Over the past decade, investing in biotech stocks with insider buying has tripled the S&P 500's return.

Tandem Diabetes Care (Nasdaq: TNDM) and Exscientia PLC (Nasdaq: EXAI) are prime examples of some I've recommended. The former was a particularly big winner, allowing my readers to lock in up to a 1,795% gain in less than one year.

Needless to say, I'm bullish on the industry.

But there's one big problem faced by most biotechs: Drug discovery.

More specifically, how long drug discovery takes and how much it costs. Drug discovery hasn't changed much in the last century. It still takes up to a decade or even more in some cases to develop a new drug.

It's a long, manual process with lots of trial and error (not to mention government red tape) that can be performed only by highly trained resources. Because of that, it's also astronomically expensive. The average cost to develop a new drug is $2.6 billion...

That's a lot of money to shell out for a drug that may not even make the cut - a full 9 out of 10 drugs entering Phase 1 clinical trials never make it to market. They get shot down by the Food and Drug Administration (FDA), often for good reason. But by that point, it's already cost billions of dollars to develop them.That's changing, though. And it's changing fast. Artificial intelligence (AI) can make drug development a faster and cheaper process with fewer costly failures.

It can shorten drug development times from a decade-plus on average to just a few short years and give us better, longer, healthier lives in the process.

And this company is using AI to support the entire biotech industry. Because, unlike many biotech companies that focus on only one specific segment of the drug development process, this company helps other biotechs make new breakout discoveries.

SPONSORED

Famous Georgia Trader Reveals #1 Trade On
Monday, Monday, July 15

Nate and Emmy Award-Winning Journalist
 

The man who once turned $37k into $2.7 Million in just 4 years and recently closed a 1,129% win after just TWO days on a livestream..

Just revealed the #1 trade to make on Monday, Monday, July 15...

All using a strategy that has produced an 81% win-rate over the past year.

See his strategy here.

In fact, it has supported 80% of all FDA-approved novel drugs that have hit the market over the past five years. If you're taking a new drug, there's a good chance this company helped develop it.

I'm expecting big things for this company because its insiders are piling in at a breakneck pace...

I think the biggest growth is just on the horizon. That's based on the fact that insiders have loaded up on $1.45 million worth of shares in the last 12 months - with some of the fastest buying happening as we were coming into the end of 2023.

Among the biggest purchases were those from the CEO, who bought 5,620 shares for just over $1 million, and the COO, who bought 1,322 shares for just under $250,000 - both in November 2023.

That's a prime example of the cluster buying that I look for - and from two of the highest-ranking executives at the company to boot...

And when I see high-level insiders plunk down big money on their own stocks, I know something big is likely to happen soon...

Following the Insiders

This company sits at a crossroads of AI, biotech and insider buying: two industries growing at an incredible pace plus the single greatest indicator I've ever seen in the market...

All in one stock.

The company's incredible technology and the niche it's carved out in the biotech industry make it a great investment...

But considering two of its highest-ranking executives are eating their own cooking to the tune of $1.2 million, this goes from a great buy to an out-and-out incredible opportunity.

I'm bullish on the biotech industry, I'm bullish on AI and I've always been bullish on companies with massive insider purchases.

This is not an opportunity you want to pass up, and it's my No. 1 insider stock pick for this year.

[Find out more details here now.]

This strategy has delivered gains as high as 1,163% in just 90 days. And today, I'm seeing signs that we could be on the verge of another massive winner.

Click here to learn how you could potentially target 10X gains by Labor Day.

Good investing,

Alex

Leave a Comment
OXF Seven

BUILD AND PROTECT YOUR WEALTH

SPONSORED

See What
One Ticker... One Trade... EVERY WEEK...
Can Do for YOU

Calendar; January - June
 

New research proves that trading one ticker every week has had the ability to produce extraordinary gains...

Including a rare 2,614% in under 11 days.

See this groundbreaking new discovery for yourself.

SHOW ME ONE TICKER PAYOUTS

No comments:

Post a Comment

Post-Election Energy Clarity

I have a feeling that any uncertainty oil and gas companies may... ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏...